Calcitonin gene-related peptide

Possible tumor marker for medullary thyroid cancer

Graeme J. Poston, Patricia K. Seitz, Courtney Townsend, Robert W. Alexander, Srinivasan Rajaraman, Cary W. Cooper, James C. Thompson

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We have sought to determine whether medullary thyroid carcinoma (MTC) released calcitonin gene-related peptide (CGRP) in vivo. MTC cells were inoculated from tissue culture into eight Wag-Rij rats. One month later blood was drawn before and after the intravenous injection of calcium, and plasma levels of CGRP and calcitonin (CT) levels in that blood were determined by radioimmunoassay. The tumor was examined for content of CGRP and of CT by means of radioimmunoassay and immunocytochemistry. The tumor was divided and portions were passed to another eight rats. One month later, the studies were repeated. The tumor was passed two additional times (four passages in all). Controls consisted of non-tumor-bearing Wag-Rij rats. Basal levels of plasma CGRP in control rats (7 ± 1 ng/ml) were unaffected by calcium stimulation. In tumor-bearing rats, the plasma CGRP level, which was initially slightly elevated (15 ± 7 ng/ml), rose progressively with passages to 279 ± 79 ng/ml in the third passage and fell to normal values at the end of passage four. Hypercalcemia had no effect on plasma CGRP levels in tumor-bearing rats but did stimulate the release of CT in both control and tumor-bearing rats, although it is not clear whether this release was from the tumor or from normal thyroid parafollicular cells in these tumor-bearing rats. We conclude that rat MTC synthesizes and releases CGRP but, unlike CT, CGRP appears unresponsive to calcium stimulation.

Original languageEnglish (US)
Pages (from-to)1049-1054
Number of pages6
JournalSurgery
Volume102
Issue number6
StatePublished - 1987
Externally publishedYes

Fingerprint

Calcitonin Gene-Related Peptide
Tumor Biomarkers
Calcitonin
Neoplasms
Calcium
Radioimmunoassay
Medullary Thyroid cancer
Hypercalcemia
Intravenous Injections
Thyroid Gland
Reference Values
Immunohistochemistry

ASJC Scopus subject areas

  • Surgery

Cite this

Poston, G. J., Seitz, P. K., Townsend, C., Alexander, R. W., Rajaraman, S., Cooper, C. W., & Thompson, J. C. (1987). Calcitonin gene-related peptide: Possible tumor marker for medullary thyroid cancer. Surgery, 102(6), 1049-1054.

Calcitonin gene-related peptide : Possible tumor marker for medullary thyroid cancer. / Poston, Graeme J.; Seitz, Patricia K.; Townsend, Courtney; Alexander, Robert W.; Rajaraman, Srinivasan; Cooper, Cary W.; Thompson, James C.

In: Surgery, Vol. 102, No. 6, 1987, p. 1049-1054.

Research output: Contribution to journalArticle

Poston, GJ, Seitz, PK, Townsend, C, Alexander, RW, Rajaraman, S, Cooper, CW & Thompson, JC 1987, 'Calcitonin gene-related peptide: Possible tumor marker for medullary thyroid cancer', Surgery, vol. 102, no. 6, pp. 1049-1054.
Poston GJ, Seitz PK, Townsend C, Alexander RW, Rajaraman S, Cooper CW et al. Calcitonin gene-related peptide: Possible tumor marker for medullary thyroid cancer. Surgery. 1987;102(6):1049-1054.
Poston, Graeme J. ; Seitz, Patricia K. ; Townsend, Courtney ; Alexander, Robert W. ; Rajaraman, Srinivasan ; Cooper, Cary W. ; Thompson, James C. / Calcitonin gene-related peptide : Possible tumor marker for medullary thyroid cancer. In: Surgery. 1987 ; Vol. 102, No. 6. pp. 1049-1054.
@article{0db436b0b4dd4457918e402daef902ff,
title = "Calcitonin gene-related peptide: Possible tumor marker for medullary thyroid cancer",
abstract = "We have sought to determine whether medullary thyroid carcinoma (MTC) released calcitonin gene-related peptide (CGRP) in vivo. MTC cells were inoculated from tissue culture into eight Wag-Rij rats. One month later blood was drawn before and after the intravenous injection of calcium, and plasma levels of CGRP and calcitonin (CT) levels in that blood were determined by radioimmunoassay. The tumor was examined for content of CGRP and of CT by means of radioimmunoassay and immunocytochemistry. The tumor was divided and portions were passed to another eight rats. One month later, the studies were repeated. The tumor was passed two additional times (four passages in all). Controls consisted of non-tumor-bearing Wag-Rij rats. Basal levels of plasma CGRP in control rats (7 ± 1 ng/ml) were unaffected by calcium stimulation. In tumor-bearing rats, the plasma CGRP level, which was initially slightly elevated (15 ± 7 ng/ml), rose progressively with passages to 279 ± 79 ng/ml in the third passage and fell to normal values at the end of passage four. Hypercalcemia had no effect on plasma CGRP levels in tumor-bearing rats but did stimulate the release of CT in both control and tumor-bearing rats, although it is not clear whether this release was from the tumor or from normal thyroid parafollicular cells in these tumor-bearing rats. We conclude that rat MTC synthesizes and releases CGRP but, unlike CT, CGRP appears unresponsive to calcium stimulation.",
author = "Poston, {Graeme J.} and Seitz, {Patricia K.} and Courtney Townsend and Alexander, {Robert W.} and Srinivasan Rajaraman and Cooper, {Cary W.} and Thompson, {James C.}",
year = "1987",
language = "English (US)",
volume = "102",
pages = "1049--1054",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Calcitonin gene-related peptide

T2 - Possible tumor marker for medullary thyroid cancer

AU - Poston, Graeme J.

AU - Seitz, Patricia K.

AU - Townsend, Courtney

AU - Alexander, Robert W.

AU - Rajaraman, Srinivasan

AU - Cooper, Cary W.

AU - Thompson, James C.

PY - 1987

Y1 - 1987

N2 - We have sought to determine whether medullary thyroid carcinoma (MTC) released calcitonin gene-related peptide (CGRP) in vivo. MTC cells were inoculated from tissue culture into eight Wag-Rij rats. One month later blood was drawn before and after the intravenous injection of calcium, and plasma levels of CGRP and calcitonin (CT) levels in that blood were determined by radioimmunoassay. The tumor was examined for content of CGRP and of CT by means of radioimmunoassay and immunocytochemistry. The tumor was divided and portions were passed to another eight rats. One month later, the studies were repeated. The tumor was passed two additional times (four passages in all). Controls consisted of non-tumor-bearing Wag-Rij rats. Basal levels of plasma CGRP in control rats (7 ± 1 ng/ml) were unaffected by calcium stimulation. In tumor-bearing rats, the plasma CGRP level, which was initially slightly elevated (15 ± 7 ng/ml), rose progressively with passages to 279 ± 79 ng/ml in the third passage and fell to normal values at the end of passage four. Hypercalcemia had no effect on plasma CGRP levels in tumor-bearing rats but did stimulate the release of CT in both control and tumor-bearing rats, although it is not clear whether this release was from the tumor or from normal thyroid parafollicular cells in these tumor-bearing rats. We conclude that rat MTC synthesizes and releases CGRP but, unlike CT, CGRP appears unresponsive to calcium stimulation.

AB - We have sought to determine whether medullary thyroid carcinoma (MTC) released calcitonin gene-related peptide (CGRP) in vivo. MTC cells were inoculated from tissue culture into eight Wag-Rij rats. One month later blood was drawn before and after the intravenous injection of calcium, and plasma levels of CGRP and calcitonin (CT) levels in that blood were determined by radioimmunoassay. The tumor was examined for content of CGRP and of CT by means of radioimmunoassay and immunocytochemistry. The tumor was divided and portions were passed to another eight rats. One month later, the studies were repeated. The tumor was passed two additional times (four passages in all). Controls consisted of non-tumor-bearing Wag-Rij rats. Basal levels of plasma CGRP in control rats (7 ± 1 ng/ml) were unaffected by calcium stimulation. In tumor-bearing rats, the plasma CGRP level, which was initially slightly elevated (15 ± 7 ng/ml), rose progressively with passages to 279 ± 79 ng/ml in the third passage and fell to normal values at the end of passage four. Hypercalcemia had no effect on plasma CGRP levels in tumor-bearing rats but did stimulate the release of CT in both control and tumor-bearing rats, although it is not clear whether this release was from the tumor or from normal thyroid parafollicular cells in these tumor-bearing rats. We conclude that rat MTC synthesizes and releases CGRP but, unlike CT, CGRP appears unresponsive to calcium stimulation.

UR - http://www.scopus.com/inward/record.url?scp=0023518695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023518695&partnerID=8YFLogxK

M3 - Article

VL - 102

SP - 1049

EP - 1054

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 6

ER -